title: Regulatory authorities review use of galantamine in mild cognitive impairment.
authors.forename: Susan
authors.initials: S
authors.lastname: Mayor
mesh_terms: D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000188:drug therapy*; D017277:Drug Approval; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans; D006113:United Kingdom
chemical_list: D002800:Cholinesterase Inhibitors; D005702:Galantamine